IP Library Assignment 064246/0762
Patent Assignment
Reel/Frame 064246/0762

Assignment of Assignor's Interest

Recorded: 2023-07-13 Pages: 10
Assignors
GRAY, NATHANAEL S.
Executed: 2017-08-03
JANNE, PASI
Executed: 2017-08-02
CHOI, HWAN GEUN
Executed: 2017-07-06
JANG, JAEBONG
Executed: 2017-08-03
Assignee
DANA-FARBER CANCER INSTITUTE, INC.
450 BROOKLINE AVENUE, BOSTON, MASSACHUSETTS, 02215-5450
Covered Property (1)
Novel Pyrimidines as Egfr Inhibitors and Methods of Treating Disorders
Application: 15/536,486 →
Publication: US 2017/0362204
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License Aug 7, 2017
From: DANA-FARBER CANCER INST
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043458/0045 →
Assignment of Assignor's Interest Aug 10, 2017
From: GRAY, NATHANAEL S.; JANNE, PASI; CHOI, HWAN GEUN; JANG, JAEBONG
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 043255/0965 →